Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

APMT Awarded $1.1 Million to Develop Biopharmaceutical Stability Technology

By PR Web | March 29, 2016

APMT utilizes $1.1 Million award from NSF to develop light scattering technology for biopharmaceutical analysis.

Advanced Polymer Monitoring Technologies, Inc. was awarded over $1.1 Million under the National Science Foundation’s Small Business Innovation Research (SBIR) program. This funding supports development of simultaneous multiple sample light scattering technology for monitoring stability and aggregation of biopharmaceuticals. APMT has also used the resulting Aggregation Rate Generator product (ARGEN) for other applications in synthetic and natural polymers. ARGEN allows measurement of stability and degradation of solutions, dispersions and suspensions under computer controlled thermal, mechanical, and chemical stimulus. Applications to date include carbon nanotubes to therapeutic proteins.

Mike Drenski, APMT’s Chief Technical Officer said, “Our ARGEN team has developed an impressive instrument incorporating proprietary hardware and software. The ARGEN product is now operational and actively generating unique data for several early users.”

The underlying patented light scattering technology was developed in Prof. Wayne Reed’s group at Tulane University’s Center for Polymer Reaction Monitoring and Characterization (PolyRMC). Ongoing research at Tulane is exploring new applications of the technology.

“Through the generous support of the National Science Foundation, we are able to work directly with selected users to generate ARGEN data on relevant samples free of charge,” said Alex Reed, APMT Chief Executive Officer. “We encourage anyone wishing to learn more about ARGEN’s capabilities in monitoring stability and aggregation in biopharmaceutical applications to contact us for more information.”

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

This is a Hemco marketing image of its MicroFlow self-contained workstation.
Hemco highlights its self-contained workstations
Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Moving toward the autonomous lab and what’s possible today
Female worker at pharmaceutical factory operating control panel of the pharmaceutical machine.
How real-time sensors and data-savvy can cut energy waste in pharma
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE